Placentas from older mothers held less NAD+, and in aged pregnant mice, nicotinamide riboside or the CD38 inhibitor 78c restored placental NAD+ and improved fetal growth.
|Articles|April 3, 2012
DailyDx: Test Your Ultrasound Skills
Author(s)Joe Antony, MD
Using only this image, describe what phase of the menstrual cycle this patient is in.
Advertisement
Using only this image, describe what phase of the menstrual cycle this patient is in.
This quiz is for the novice.
Add your description to the comment box and continue to the diagnosis!
The answer is: the endometrium during menstrual phase
We challenge you to stump your colleagues! Send us your
Advertisement
Related to this article
A real-world study presented at Psych Congress found that zuranolone's PPD symptom improvements were sustained through day 90.
Maternal RSV immunization creates an important opportunity for obstetric and pediatric clinicians to coordinate newborn prevention strategies, according to Kevin Ault, MD.
Drawing on her own successful version, Amber Watters, MD, welcomes the ASA's push for closer obstetrics and anesthesia collaboration.
SMFM states abortion care is core to MFM practice and urges institutional action to protect high-risk patient access.
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
Amber Watters, MD, MS, explains that emergent delivery after external cephalic version is exceedingly rare and fits within existing protocols, and outlines how to build a version program.
Positively Pregnant translates cycle day and cycle length research into individualized pregnancy test sensitivity estimates, according to Alexandra C. Sundermann, MD, PhD.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Contemporary OB/GYN launches 'Missed & Dismissed' podcast to explore diagnostic gaps in women's health
2
Menopause proteomic scores associated with cognitive aging, dementia risk
3
FDA approves IDE for pivotal study of Evident ovarian cancer screening test
4
Q&A: Anita Nelson, MD, on etonogestrel implant's 5-year approval and REMS certification
5